LOW Ex-Dividend Reminder - 10/21/13

Looking at the universe of stocks we cover at Dividend Channel, on 10/21/13, Lowe's Companies Inc (LOW) will trade ex-dividend, for its quarterly dividend of $0.18, payable on 11/6/13. As a percentage of LOW's recent stock price of $48.42, this dividend works out to approximately 0.37%.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for LOW, showing historical dividends prior to the most recent $0.18 declared by Lowe's Companies Inc:

LOW+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from LOW is likely to continue, and whether the current estimated yield of 1.49% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of LOW shares, versus its 200 day moving average:

Lowe's Companies Inc 200 Day Moving Average Chart

Looking at the chart above, LOW's low point in its 52 week range is $31.17 per share, with $49.17 as the 52 week high point — that compares with a last trade of $48.53.

According to the ETF Finder at ETF Channel, LOW makes up 5.01% of the Retail ETF ( RTH) which is trading lower by about 0.2% on the day Thursday.

In Thursday trading, Lowe's Companies Inc shares are currently off about 0.1% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says